ID: ALA230346

Max Phase: Preclinical

Molecular Formula: C24H28O2

Molecular Weight: 348.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=CCc1cc(/C(CC)=C(\CC)c2ccc(O)c(CC=C)c2)ccc1O

Standard InChI:  InChI=1S/C24H28O2/c1-5-9-19-15-17(11-13-23(19)25)21(7-3)22(8-4)18-12-14-24(26)20(16-18)10-6-2/h5-6,11-16,25-26H,1-2,7-10H2,3-4H3/b22-21+

Standard InChI Key:  NUKHDOPGAIWQMC-QURGRASLSA-N

Associated Targets(Human)

CCRF-CEM 65223 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

SVR 53 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Human immunodeficiency virus 1 70413 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vero 26788 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 348.49Molecular Weight (Monoisotopic): 348.2089AlogP: 6.29#Rotatable Bonds: 8
Polar Surface Area: 40.46Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.43CX Basic pKa: CX LogP: 7.39CX LogD: 7.35
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.43Np Likeness Score: 0.45

References

1. Amblard F, Govindarajan B, Lefkove B, Rapp KL, Detorio M, Arbiser JL, Schinazi RF..  (2007)  Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.,  17  (16): [PMID:17587572] [10.1016/j.bmcl.2007.06.024]
2. Lin D, Yan Z, Chen A, Ye J, Hu A, Liu J, Peng J, Wu X..  (2019)  Anti-proliferative activity and structure-activity relationship of honokiol derivatives.,  27  (16): [PMID:31278004] [10.1016/j.bmc.2019.06.042]

Source